Literature DB >> 21927630

Atomoxetine facilitates attentional set shifting in adolescent rats.

Rachel E Cain1, Michelle C Wasserman, Barry D Waterhouse, Jill A McGaughy.   

Abstract

Adolescent rats show immaturities in executive function and are less able than adult rats to learn reinforcement reversals and shift attentional set. These two forms of executive function rely on the functional integrity of the orbitofrontal and prelimbic cortices respectively. Drugs used to treat attention deficit disorder, such as atomoxetine, that increase cortical catecholamine levels improve executive functions in humans, non-human primates and adult rats with prefrontal lesions. Cortical noradrenergic systems are some of the last to mature in primates and rats. Moreover, norepinephrine transporters (NET) are higher in juvenile rats than adults. The underdeveloped cortical noradrenergic system and higher number of NET are hypothesized to underlie the immaturities in executive function found in adolescents. We assessed executive function in male Long-Evans rats using an intra-dimensional/extradimensional set shifting task. We administered the NET blocker, atomoxetine (0.0, 0.1, 0.9 mg/kg/ml; i.p.), prior to the test of attentional set shift and a reinforcement reversal. The lowest dose of drug facilitated attentional set shifting but had no effect on reversal learning. These data demonstrate that NET blockade allows adolescent rats to more easily perform attentional set shifting.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21927630      PMCID: PMC3172139          DOI: 10.1016/j.dcn.2011.04.003

Source DB:  PubMed          Journal:  Dev Cogn Neurosci        ISSN: 1878-9293            Impact factor:   6.464


  97 in total

Review 1.  Addiction, dopamine, and the molecular mechanisms of memory.

Authors:  J D Berke; S E Hyman
Journal:  Neuron       Date:  2000-03       Impact factor: 17.173

2.  A neural circuit for circadian regulation of arousal.

Authors:  G Aston-Jones; S Chen; Y Zhu; M L Oshinsky
Journal:  Nat Neurosci       Date:  2001-07       Impact factor: 24.884

3.  Executive cognitive functions and impulsivity as correlates of risk taking and problem behavior in preadolescents.

Authors:  Daniel Romer; Laura Betancourt; Joan M Giannetta; Nancy L Brodsky; Martha Farah; Hallam Hurt
Journal:  Neuropsychologia       Date:  2009-06-26       Impact factor: 3.139

4.  Adolescent rats show cognitive rigidity in a test of attentional set shifting.

Authors:  Lori A Newman; Jill McGaughy
Journal:  Dev Psychobiol       Date:  2011-03-01       Impact factor: 3.038

Review 5.  Fundamentals of attention-deficit/hyperactivity disorder: circuits and pathways.

Authors:  Amy F T Arnsten
Journal:  J Clin Psychiatry       Date:  2006       Impact factor: 4.384

Review 6.  Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder.

Authors:  Christopher J Kratochvil; Brigette S Vaughan; Martin J Harrington; William J Burke
Journal:  Expert Opin Pharmacother       Date:  2003-07       Impact factor: 3.889

7.  A new inhibitor of norepinephrine uptake devoid of affinity for receptors in rat brain.

Authors:  D T Wong; P G Threlkeld; K L Best; F P Bymaster
Journal:  J Pharmacol Exp Ther       Date:  1982-07       Impact factor: 4.030

8.  Atomoxetine reverses attentional deficits produced by noradrenergic deafferentation of medial prefrontal cortex.

Authors:  Lori A Newman; Jenna Darling; Jill McGaughy
Journal:  Psychopharmacology (Berl)       Date:  2008-06-22       Impact factor: 4.530

9.  Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

Authors:  Jeffrey H Newcorn; Christopher J Kratochvil; Albert J Allen; Charles D Casat; Dustin D Ruff; Rodney J Moore; David Michelson
Journal:  Am J Psychiatry       Date:  2008-02-15       Impact factor: 18.112

10.  Atomoxetine improved response inhibition in adults with attention deficit/hyperactivity disorder.

Authors:  Samuel R Chamberlain; Natalia Del Campo; Jonathan Dowson; Ulrich Müller; Luke Clark; Trevor W Robbins; Barbara J Sahakian
Journal:  Biol Psychiatry       Date:  2007-07-17       Impact factor: 13.382

View more
  21 in total

Review 1.  Prefrontal cortex executive processes affected by stress in health and disease.

Authors:  Milena Girotti; Samantha M Adler; Sarah E Bulin; Elizabeth A Fucich; Denisse Paredes; David A Morilak
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-07-06       Impact factor: 5.067

2.  Cognitive impact of social stress and coping strategy throughout development.

Authors:  Kevin P Snyder; Mark Barry; Rita J Valentino
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

3.  Heterogeneous organization of the locus coeruleus projections to prefrontal and motor cortices.

Authors:  Daniel J Chandler; Wen-Jun Gao; Barry D Waterhouse
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-21       Impact factor: 11.205

4.  Differentiation of rodent behavioral phenotypes and methylphenidate action in sustained and flexible attention tasks.

Authors:  Richard Chu; Jed Shumsky; Barry D Waterhouse
Journal:  Brain Res       Date:  2015-12-10       Impact factor: 3.252

5.  Attention enhancing effects of methylphenidate are age-dependent.

Authors:  Shevon E Bhattacharya; Jed S Shumsky; Barry D Waterhouse
Journal:  Exp Gerontol       Date:  2014-11-11       Impact factor: 4.032

6.  Methylphenidate and atomoxetine enhance sensory-evoked neuronal activity in the visual thalamus of male rats.

Authors:  Rachel L Navarra; Brian D Clark; Gerard A Zitnik; Barry D Waterhouse
Journal:  Exp Clin Psychopharmacol       Date:  2013-10       Impact factor: 3.157

7.  Performance on a strategy set shifting task in rats following adult or adolescent cocaine exposure.

Authors:  Kathleen M Kantak; Nicole Barlow; David H Tassin; Madeline F Brisotti; Chloe J Jordan
Journal:  Psychopharmacology (Berl)       Date:  2014-05-07       Impact factor: 4.530

Review 8.  Reducing substance use during adolescence: a translational framework for prevention.

Authors:  Jessica J Stanis; Susan L Andersen
Journal:  Psychopharmacology (Berl)       Date:  2014-01-25       Impact factor: 4.530

9.  Age-related changes in prefrontal norepinephrine transporter density: The basis for improved cognitive flexibility after low doses of atomoxetine in adolescent rats.

Authors:  Sarah E Bradshaw; Kara L Agster; Barry D Waterhouse; Jill A McGaughy
Journal:  Brain Res       Date:  2016-01-14       Impact factor: 3.252

10.  Characterization of electrically evoked field potentials in the medial prefrontal cortex and orbitofrontal cortex of the rat: modulation by monoamines.

Authors:  Joanne Wallace; Rosanna K Jackson; Tanya L Shotton; Ishaana Munjal; Richard McQuade; Sarah E Gartside
Journal:  Eur Neuropsychopharmacol       Date:  2013-08-06       Impact factor: 4.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.